Selected article for: "BTM testing and control measure"
Author: ISODA, Norikazu; ASANO, Akihiro; ICHIJO, Michiru; OHNO, Hiroshi; SATO, Kazuhiko; OKAMOTO, Hirokazu; NAKAO, Shigeru; KATO, Hajime; SAITO, Kazuma; ITO, Naoki; USUI, Akira; TAKAYAMA, Hiroaki; SAKODA, Yoshihiro
Title: Assessment of the cost effectiveness of compulsory testing of introduced animals and bulk tank milk testing for bovine viral diarrhea in Japan
  • Document date: 2019_3_1
    • ID: 3ivoabj1_30
    Snippet: Interestingly, regardless of the target population of compulsory testing, BVD prevalence under the control measure with BTM testing decreased and converged in a shorter period than that without it, though the process that resulted in BVDV prevalence convergence were different among the scenarios. These results would be a base of politic decision for selection of BVD control measures given the estimated cost for implementation, degree of risk redu.....
    Document: Interestingly, regardless of the target population of compulsory testing, BVD prevalence under the control measure with BTM testing decreased and converged in a shorter period than that without it, though the process that resulted in BVDV prevalence convergence were different among the scenarios. These results would be a base of politic decision for selection of BVD control measures given the estimated cost for implementation, degree of risk reduction as well as terminated BVDV prevalence.

    Search related documents:
    Co phrase search for related documents
    • BVD prevalence and compulsory testing: 1, 2, 3, 4, 5, 6
    • BVD prevalence and control measure: 1, 2
    • BVD prevalence and risk reduction: 1
    • BVDV prevalence and compulsory testing: 1, 2, 3, 4, 5, 6
    • BVDV prevalence and control measure: 1, 2
    • BVDV prevalence and prevalence convergence: 1
    • BVDV prevalence convergence and compulsory testing: 1
    • BVDV prevalence convergence and prevalence convergence: 1
    • compulsory testing and control measure: 1, 2, 3, 4, 5
    • compulsory testing and prevalence convergence: 1
    • compulsory testing and short period: 1
    • control measure and risk reduction: 1, 2, 3, 4, 5, 6, 7
    • control measure and short period: 1, 2
    • estimate cost and implementation estimate cost: 1
    • risk reduction and short period: 1, 2
    • risk reduction and target population: 1, 2, 3, 4, 5, 6
    • short period and target population: 1, 2